Comorbidities in multiple sclerosis-a plea for interdisciplinary collaboration to improve the quality of life of MS patients [0.03%]
共病与多发性硬化症——提高多发性硬化患者生活质量的多学科协作呼吁
Hans-Klaus Goischke
Hans-Klaus Goischke
The negative influence of comorbidities on the quality of life of people with multiple sclerosis is evident and the problem is increasingly acknowledged by numerous international studies in long-term care. One therapeutic option would be an...
Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials [0.03%]
多项随机对照试验的文献综述得出的多发性硬化急性复发治疗疗效、安全性和生活质量结果
Jessica Costello,Annete Njue,Matthew Lyall et al.
Jessica Costello et al.
Background: Intravenous methylprednisolone (IVMP), repository corticotropin injection (RCI), plasmapheresis (PMP), and intravenous immunoglobulin (IVIG) are used in the treatment of acute multiple sclerosis (MS) relapse. ...
Trajche Ivanovski,Francesc Miralles
Trajche Ivanovski
Lambert-Eaton myasthenic syndrome (LEMS) is an uncommon disorder of neuromuscular transmission with distinctive pathophysiological, clinical, electrophysiological and laboratory features. There are two forms of LEMS. The paraneoplastic (P-L...
Giancarlo Garuti,Fabrizio Rao,Viviana Ribuffo et al.
Giancarlo Garuti et al.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder of the motor neuron, which selectively affects it both at central (first motor-neuron) and peripheral level (second motor-neuron). The disease shows up at a mea...
Physical therapy for individuals with amyotrophic lateral sclerosis: current insights [0.03%]
肌萎缩侧索硬化患者的物理治疗：当前观点
Vanina Dal Bello-Haas
Vanina Dal Bello-Haas
Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative, and inevitably fatal disease. There is no cure for ALS and life expectancy is typically 2-5 years after symptom onset. Despite the lack of a cure and the rapidly progr...
Music and dementia [0.03%]
音乐与痴呆症
Balakrishnan R Nair,William Browne,John Marley et al.
Balakrishnan R Nair et al.
As the population ages, the prevalence of dementia is increasing. Distressing behavioral problems are often part of the illness. This review considers the available evidence for cognitive effects related to music, evidence for the efficacy ...
Knowledge among physical education professionals about poliomyelitis and post-poliomyelitis syndrome: a cross-sectional study in Brazil [0.03%]
巴西体育专业人员关于脊髓灰质炎和脊髓灰质炎后综合征知识的横断面研究
Claudio Andre Barbosa de Lira,Taíza Márcia de Almeida Alves,Luiz Fernando Peixinho-Pena et al.
Claudio Andre Barbosa de Lira et al.
Background: Post-poliomyelitis syndrome is a clinical condition that can affect poliomyelitis survivors with the onset of new symptoms several years after the acute disease. These symptoms include new muscular weakness, f...
Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes [0.03%]
帕金森综合征诊断中DaTscan的临床应用价值
Andreas-Antonios Roussakis,Paola Piccini,Marios Politis
Andreas-Antonios Roussakis
The diagnosis of movement disorders including Parkinsonian syndromes and essential tremor is mainly clinical. The most common diagnostic errors for Parkinson's disease include misdiagnoses such as Parkinson plus syndromes and cases of essen...
The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration [0.03%]
假性球麻痹的流行病学、病理生理及其与神经退行性疾病的关系
Rebecca R King,Jeffrey P Reiss
Rebecca R King
Pseudobulbar affect is a disorder resulting from neurologic damage manifesting as sudden, stereotyped affective outbursts that are not reflective of internal emotion. A literature review was completed to examine the current understanding of...
C M Bloom,R J Post,A M Anch et al.
C M Bloom et al.
Taiep (tremor, ataxia, immobility, epilepsy, paralysis) mutants show a significant increase in myelin thickness from 10 to 30 days of age but then demonstrate a decrease in myelin thickness from 1 to 6 months. The severity of the demyelinat...